These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 8208413

  • 1. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons.
    Brod SA, Burns DK.
    Neurology; 1994 Jun; 44(6):1144-8. PubMed ID: 8208413
    [Abstract] [Full Text] [Related]

  • 2. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA, al-Sabbagh A, Sobel RA, Hafler DA, Weiner HL.
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [Abstract] [Full Text] [Related]

  • 3. Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons.
    Brod SA, Scott M, Burns DK, Phillips JT.
    J Interferon Cytokine Res; 1995 Feb; 15(2):115-22. PubMed ID: 8590314
    [Abstract] [Full Text] [Related]

  • 4. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis.
    Brod SA, Khan M, Kerman RH, Pappolla M.
    J Neuroimmunol; 1995 Apr; 58(1):61-9. PubMed ID: 7537281
    [Abstract] [Full Text] [Related]

  • 5. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis.
    Brod SA, Khan M.
    J Autoimmun; 1996 Feb; 9(1):11-20. PubMed ID: 8845048
    [Abstract] [Full Text] [Related]

  • 6. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse.
    Brown AM, McFarlin DE.
    Lab Invest; 1981 Sep; 45(3):278-84. PubMed ID: 6792424
    [Abstract] [Full Text] [Related]

  • 7. Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion.
    Brod SA, Khan M, Nelson LD, Decuir B, Malone M, Henninger E.
    J Immunother; 2000 Sep; 23(2):235-45. PubMed ID: 10746550
    [Abstract] [Full Text] [Related]

  • 8. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA, Weiner HL.
    Proc Natl Acad Sci U S A; 1996 Jan 09; 93(1):388-91. PubMed ID: 8552644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Meyer AL, Benson JM, Gienapp IE, Cox KL, Whitacre CC.
    J Immunol; 1996 Nov 01; 157(9):4230-8. PubMed ID: 8892661
    [Abstract] [Full Text] [Related]

  • 11. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y, Inaba Y, Matsuda K, Itoh M, Kaneyama T, Nakazawa Y, Koh CS, Ichikawa M.
    J Neurol Sci; 2014 May 15; 340(1-2):117-22. PubMed ID: 24655735
    [Abstract] [Full Text] [Related]

  • 12. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
    Chen Y, Inobe J, Weiner HL.
    J Immunol; 1995 Jul 15; 155(2):910-6. PubMed ID: 7541826
    [Abstract] [Full Text] [Related]

  • 13. Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis.
    al-Sabbagh AM, Goad EP, Weiner HL, Nelson PA.
    J Neurosci Res; 1996 Aug 15; 45(4):424-9. PubMed ID: 8872902
    [Abstract] [Full Text] [Related]

  • 14. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H.
    J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788
    [Abstract] [Full Text] [Related]

  • 15. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes.
    Slavin AJ, Maron R, Weiner HL.
    Int Immunol; 2001 Jun 01; 13(6):825-33. PubMed ID: 11369711
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ, Bai XF, Shi FD, Xiao BG, Li HL, Levi M, Mustafa M, Wahren B, Link H.
    Int Immunol; 1998 Aug 01; 10(8):1139-48. PubMed ID: 9723700
    [Abstract] [Full Text] [Related]

  • 19. Immunomodulation of relapsing experimental allergic encephalomyelitis.
    Lublin FD.
    Neurology; 1984 Dec 01; 34(12):1615-7. PubMed ID: 6209597
    [Abstract] [Full Text] [Related]

  • 20. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
    Tan LJ, Kennedy MK, Miller SD.
    J Immunol; 1992 May 01; 148(9):2748-55. PubMed ID: 1374098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.